MX2023004791A - Sintesis del cocristal 1:1:1 de 1-ciano-2-(4-ciclopropil-bencil)-4 -(beta-d-glucopiranos-1-il)-benceno, l-prolina y agua. - Google Patents

Sintesis del cocristal 1:1:1 de 1-ciano-2-(4-ciclopropil-bencil)-4 -(beta-d-glucopiranos-1-il)-benceno, l-prolina y agua.

Info

Publication number
MX2023004791A
MX2023004791A MX2023004791A MX2023004791A MX2023004791A MX 2023004791 A MX2023004791 A MX 2023004791A MX 2023004791 A MX2023004791 A MX 2023004791A MX 2023004791 A MX2023004791 A MX 2023004791A MX 2023004791 A MX2023004791 A MX 2023004791A
Authority
MX
Mexico
Prior art keywords
proline
water
glucopyranos
cyclopropyl
cyano
Prior art date
Application number
MX2023004791A
Other languages
English (en)
Inventor
Frank Himmelsbach
Matthias Eckhardt
Xiao-Jun Wang
Monika Brink
Stefan Sahli
Chutian Shu
Beat Theodor Weber
Bing-Shiou Yang
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of MX2023004791A publication Critical patent/MX2023004791A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/50—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C07C69/614—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety of phenylacetic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/207—Cyclohexane rings not substituted by nitrogen atoms, e.g. kasugamycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/04—Carbocyclic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La invención se refiere a un proceso para la elaboración del compuesto cristalino de acuerdo con la fórmula (I) que comprende las siguientes etapas: (a) desacetilar el intermediario final (IF), (b) formar el compuesto cristalino de acuerdo con la fórmula (I) al hacer reaccionar el intermediario final desacetilado de la etapa (a) con L-prolina y agua y aislar el producto de reacción final; procesos de elaboración de intermediarios de este; intermediarios de proceso y sus usos en los procesos de acuerdo con la presente invención. (ver Fórmulas).
MX2023004791A 2017-12-19 2018-12-17 Sintesis del cocristal 1:1:1 de 1-ciano-2-(4-ciclopropil-bencil)-4 -(beta-d-glucopiranos-1-il)-benceno, l-prolina y agua. MX2023004791A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17208315 2017-12-19
PCT/EP2018/085193 WO2019121509A1 (en) 2017-12-19 2018-12-17 Synthesis of the 1 :1 :1 co-crystal of 1 -cyano-2-(4-cyclopropyl-benzyl)-4-(beta-d-glucopyranos-1 -yl)-benzene, l-proline and water

Publications (1)

Publication Number Publication Date
MX2023004791A true MX2023004791A (es) 2023-12-07

Family

ID=60673927

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2020006387A MX2020006387A (es) 2017-12-19 2018-12-17 Sintesis del cocristal 1:1:1 de 1-ciano-2-(4-ciclopropil-bencil)-4 -(beta-d-glucopiranos-1-il)-benceno, l-prolina y agua.
MX2023004791A MX2023004791A (es) 2017-12-19 2018-12-17 Sintesis del cocristal 1:1:1 de 1-ciano-2-(4-ciclopropil-bencil)-4 -(beta-d-glucopiranos-1-il)-benceno, l-prolina y agua.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2020006387A MX2020006387A (es) 2017-12-19 2018-12-17 Sintesis del cocristal 1:1:1 de 1-ciano-2-(4-ciclopropil-bencil)-4 -(beta-d-glucopiranos-1-il)-benceno, l-prolina y agua.

Country Status (10)

Country Link
US (2) US11225500B2 (es)
EP (1) EP3668846A1 (es)
JP (3) JP2021506962A (es)
KR (1) KR20200101421A (es)
CN (1) CN111511725B (es)
AU (1) AU2018387110B2 (es)
CA (1) CA3085671A1 (es)
EA (1) EA202091466A1 (es)
MX (2) MX2020006387A (es)
WO (1) WO2019121509A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2022006490A (es) 2019-11-28 2022-07-04 Boehringer Ingelheim Vetmedica Gmbh Uso de inhibidores de sglt-2 en el secado de mamiferos no humanos.
EP4106744A1 (en) 2020-02-17 2022-12-28 Boehringer Ingelheim Vetmedica GmbH Use of sglt-2 inhibitors for the prevention and/or treatment of cardiac diseases in felines
CA3224673A1 (en) 2021-07-28 2023-02-02 Boehringer Ingelheim Vetmedica Gmbh Use of sglt-2 inhibitors for the prevention and/or treatment of renal diseases in non-human mammals
WO2023006745A1 (en) 2021-07-28 2023-02-02 Boehringer Ingelheim Vetmedica Gmbh Use of sglt-2 inhibitors for the prevention and/or treatment of hypertension in non-human mammals
CN117715640A (zh) 2021-07-28 2024-03-15 勃林格殷格翰动物保健有限公司 Sglt-2抑制剂用于在不包括猫科动物的非人哺乳动物，特别是犬科动物中预防和/或治疗心脏疾病的用途
WO2023227492A1 (en) 2022-05-25 2023-11-30 Boehringer Ingelheim Vetmedica Gmbh Aqueous pharmaceutical compositions comprising sglt-2 inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2369016T3 (es) * 2006-02-15 2011-11-24 Boehringer Ingelheim International Gmbh Derivados de benzonitrilo sustituidos por glucopiranosilo, composiciones farmacéuticas que contienen tales tipos de compuestos, su uso y procedimiento para su fabricación.
KR20080102395A (ko) * 2006-02-15 2008-11-25 베링거 인겔하임 인터내셔날 게엠베하 글루코피라노실-치환된 벤조니트릴 유도체, 당해 화합물을 함유하는 약제학적 조성물, 이들의 용도 및 이들의 제조방법
PE20080697A1 (es) * 2006-05-03 2008-08-05 Boehringer Ingelheim Int Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmaceuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricacion
WO2008101938A1 (en) * 2007-02-21 2008-08-28 Boehringer Ingelheim International Gmbh Glucopyranosyl-substituted benzyl-benzonitrile derivatives, medicaments containing such compounds, their use and process for their manufacture
US9145434B2 (en) 2012-07-26 2015-09-29 Boehringer Ingelheim International Gmbh Crystalline complex of 1-cyano-2-(4-cyclopropyl-benzyl)-4-(ss-d-glucopyranos-1-yl)-benzene, methods for its preparation and the use thereof for preparing medicaments
WO2014184248A2 (en) * 2013-05-15 2014-11-20 Acturum Life Science AB Trpa1 antagonist compounds
MX2016012705A (es) * 2014-04-01 2016-12-16 Boehringer Ingelheim Vetmedica Gmbh Tratamiento de trastornos metabolicos en animales equinos.
US10633372B2 (en) * 2015-02-27 2020-04-28 Msn Laboratories Private Limited Process for the preparation of amorphous (1S)-1,5-anhydro-1-[3-[[5-(4 fluorophenyl)-2-thienyl]-4-methylphenyl]-D-glucitol and its polymorphs thereof
ES2800828T3 (es) * 2015-04-09 2021-01-04 Orion Corp Proceso para la preparación de antagonistas de receptor androgénico e intermedios de los mismos

Also Published As

Publication number Publication date
US20210139520A1 (en) 2021-05-13
JP2021506962A (ja) 2021-02-22
CA3085671A1 (en) 2019-06-27
AU2018387110B2 (en) 2023-02-23
WO2019121509A1 (en) 2019-06-27
MX2020006387A (es) 2020-09-03
EA202091466A1 (ru) 2020-10-23
US20220081461A1 (en) 2022-03-17
JP2023166398A (ja) 2023-11-21
EP3668846A1 (en) 2020-06-24
US11225500B2 (en) 2022-01-18
CN111511725B (zh) 2024-04-09
JP2021193102A (ja) 2021-12-23
AU2018387110A1 (en) 2020-07-16
KR20200101421A (ko) 2020-08-27
JP7387683B2 (ja) 2023-11-28
US11629161B2 (en) 2023-04-18
CN111511725A (zh) 2020-08-07

Similar Documents

Publication Publication Date Title
MX2023004791A (es) Sintesis del cocristal 1:1:1 de 1-ciano-2-(4-ciclopropil-bencil)-4 -(beta-d-glucopiranos-1-il)-benceno, l-prolina y agua.
JOP20210065A1 (ar) عملية لتحضير 5- فلورو-1h- بيرازولوبيريدينات مستبدلة
EA202090917A1 (ru) Получение псилоцибина, различных полиморфных форм, промежуточных соединений, составов и их применение
MY172391A (en) Processes for preparing dihydropyrimidine derivatives and intermediates thereof
MY201120A (en) Intermediates for use in a process of producing pyrrole compounds
MY145818A (en) Process for producing ethylene
WO2009035130A3 (en) Process for producing 2,3,3,3-tetrafluoropropene
MX2013011257A (es) Proceso para la preparacion de dronedarona por n-butilacion.
MX2009008196A (es) Nuevo procedimiento de sintesis de la agomelatina.
NZ586187A (en) Processes for the synthesis of sinomenine derivatives and their intermediate
AU2016237099B2 (en) Method for producing novel nitrogen-containing compound or salt thereof, and production intermediate of same
MX2018014128A (es) 6.7.beta-epoxidos esteroideos como intermedios quimicos.
DE602007011250D1 (de) Herstellungsverfahren für Drospirenon
MX2020010773A (es) Metodo para la preparacion del compuesto de pirroloaminopiridazino na y sus intermedios.
MX2018008936A (es) Metodo de fabricacion para alcohol de cadena larga de ciclohexenona de alta pureza.
BR112012013582A2 (pt) processo para síntese de intermediários úteis para a produção de compostos de indazol e azaindazol substituídos
MY165659A (en) Novel method of preparing benzoimidazole derivatives
GEP20135747B (en) Method of benzonorbornenes production
MX2021001732A (es) Preparacion de intermedio util para la sintesis de inhibidor de sglt.
WO2012113999A8 (fr) Procede et intermediaires de synthese de l ' agomelatine
WO2016071920A3 (en) A process for preparation of 3,4-dimethylbenzaldehyde
EP4249491A3 (en) Process for preparing bicyclic enolether
MX2021001530A (es) Metodo de produccion de esteres carbonicos.
MX2010012764A (es) Proceso para la preparacion de un componente intermedia para sintetizar un anticoagulante.
MX2017009839A (es) Proceso para la produccion de derivados de imidazolo condensados.